MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-02-0023666
Retero Life Sciences Private Limited
Retero Life Sciences Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹1.8 Cr
▼ 55% YoY
Net profit · FY 2023
₹4.94 Lakh
Net margin 2.7%
EBITDA · FY 2023
₹7.12 Lakh
EBITDA margin 4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1 Cr
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About Retero Life Sciences Private Limited
Data last updated:
Retero Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 17 January 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2018PTC121898. Its GSTIN is 36AAICR7234C1ZG (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sambasivarao Narra and Narra Kavitha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No: 7 – 1 – 643 Flat No: 109 Block B Bhanu Enclave Sundar Nagar Erragadda, Hyderabad, Telangana, India – 500038.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.8 Cr, a decline of 55% compared to the previous year. For the same year it recorded a net profit of ₹4.94 Lakh (net margin 2.7%) and EBITDA of ₹7.12 Lakh (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.
The company is associated with 1 brand: Retero life sciences. As per MCA filings, the company has open charges of ₹1 Cr on record.
Retero Life Sciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0023666).
Company details
CIN U24304TG2018PTC121898
Registration Number 121898
Incorporation Date 17 January 2018
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0023666
Recognitions & Rankings of Retero Life Sciences
Contact details
Retero Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressNo: 7 – 1 – 643 Flat No: 109 Block B Bhanu Enclave Sundar Nagar Erragadda, Hyderabad, Telangana, India – 500038
- IndustryPharma, API Manufacturers
To see the full contact details of Retero Life Sciences Private Limited, buy the company report.
Comprehensive company report
Retero Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Retero Life Sciences operates one associated brand: Retero life sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Functions as a CDMO focused on API intermediates manufacturing. | reterolifesciences.com |
Financials of Retero Life Sciences Private Limited
FY 2025 filings availableRetero Life Sciences Private Limited reported revenue of ₹1.8 Cr (down 55% YoY) for FY 2023.
Revenue · FY 2023
₹1.8 Cr ▼ 55%
Net profit · FY 2023
₹4.94 Lakh margin 2.7%
EBITDA · FY 2023
₹7.12 Lakh margin 4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 55%
3 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▼ 50%
3 years · compounded
▲ 19%
Revenue fell 55% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA fell 50% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.8 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.12 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.94 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Retero Life Sciences Private Limited, buy the company report.
Board of directors of Retero Life Sciences Private Limited
Retero Life Sciences has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sambasivarao Narra | Director | 16 Jul 2019 | 7 Years 3 Months | Current |
| Narra Kavitha | Director | 15 Apr 2022 | 4 Years 6 Months | Current |
Auditor
Retero Life Sciences Private Limited is audited by G V M K & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G V M K & CO | FY 2023 | 025868S |
Shareholding
The shareholding of Retero Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Retero Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Sep 2025 | 101170955 | Others | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Retero Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Retero Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Retero Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICR7234C1ZG | Telangana | Active | 24 Mar 2018 |
To see the full GST registrations and return filing status of Retero Life Sciences Private Limited, buy the company report.
Recent activity
Retero Life Sciences Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Vakula Devi Neelapala ceased to be Director on 09 Sep 2022.
AGM
Retero Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 100.00 Lakh with Charge ID 101170955 was registered on 25 Sep 2025.
Filing
Retero Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Vakula Devi Neelapala ceased to be Director.
Appointed
Narra Kavitha was appointed as Director.
Ceased
Suresh Valasapalli ceased to be Director.
Ceased
Sambasivarao Narra ceased to be Additional Director.
Appointed
Sambasivarao Narra was appointed as Director.
Incorporation
17 Jan 2018
Retero Life Sciences Private Limited was registered on 17 Jan 2018 with Roc Hyderabad & aged 8 years 9 months as per MCA records.
Frequently asked questions
Retero Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 17 January 2018 (8+ years old) and is registered under CIN U24304TG2018PTC121898.
Retero Life Sciences has 2 current directors:
- Sambasivarao Narra - Director
- Narra Kavitha - Director
The latest financial statements of Retero Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Retero Life Sciences is 36AAICR7234C1ZG, registered in Telangana.
The CIN (Corporate Identification Number) of Retero Life Sciences is U24304TG2018PTC121898. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Retero Life Sciences was incorporated on 17 January 2018, making it 8+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vakula Devi Neelapala ceased to be Director on 09 Sep 2022. Narra Kavitha was appointed as Director on 15 Apr 2022. Suresh Valasapalli ceased to be Director on 28 Aug 2020. Retero Life Sciences has 5 board changes on record in total.
Yes, Retero Life Sciences is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0023666).
The registered office of Retero Life Sciences is at No: 7 – 1 – 643 Flat No: 109 Block B Bhanu Enclave Sundar Nagar Erragadda, Hyderabad, Telangana, India – 500038.
Retero Life Sciences operates in the pharma industry, in the api manufacturers segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages